Effects of C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase on weight loss and cardiovascular risk factors 1 year after biliopancreatic diversion surgery

Surgery for Obesity and Related Diseases

Volumn 6, Issue 5, 2010, Pages 516-520

  De Luis, D A ^a   Sagrado, M Gonzalez ^a   Pacheco, D ^a   Terroba, M C ^a   Martin, T ^a   Cuellar, L ^a   Ventosa, M ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Bariatric surgery; Fatty acid amide hydrolase; Morbid obesity; Polymorphism

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; FATTY ACID AMIDASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BILIOPANCREATIC BYPASS; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME DEGRADATION; FEEDING BEHAVIOR; FEMALE; FOLLOW UP; GENE FREQUENCY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MORBID OBESITY; MUTANT; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; WILD TYPE;

ADULT; ALLELES; AMIDOHYDROLASES; BILIOPANCREATIC DIVERSION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COMORBIDITY; ENDOCANNABINOIDS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIPIDS; MALE; OBESITY, MORBID; POLYMORPHISM, GENETIC; RISK FACTORS; STATISTICS, NONPARAMETRIC; WEIGHT LOSS;

EID: 77957579289     PISSN: 15507289     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soard.2010.01.005     Document Type: Article

References (18)

1. J. Aranceta, C. Perez Rodrigo, and L. Serra Majem Prevalencia de la obesidad en Espaa: estudio SEEDO 97 Med Clin (Barc) 111 1998 441 445
2. D.A. de luis, R. Aller, O. Izaola, and D. Pacheco Early clinical and surgical results of biliopancreatic diversion Obes Surg 15 2005 799 802
3. N. Scopinaro, G.F. Adami, and G.M. Marinari Biliopancreatic diversion World J Surg 22 1998 936 946
4. V. Di Marzo Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov 7 2008 438 455
5. V. Di Marzo The endocannabinoid system in obesity and type 2 diabetes Diabetologia 51 2008 1356 1367
6. D.G. Deustch, N. Ueda, and S. Yammamoto The fatty acid amide hydrolase (FAAH) 1 Prostaglandins Leukot Essent Fatty Acids 66 2002 201 210
7. J.C. Sipe, J. Waalen, A. Gerber, and E. Beutler Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH) Int J Obes 29 2005 755 759
8. P. Monteleone, A. Tortorella, V. Martiadis, C. Filippo, B. Canestrelli, and M. Maj The CDNA 385 C to A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) is associated with overweight/obesity but not with binge eating disorder in overweight/obese women Psychoneuroendocrinology 33 2008 546 550
9. D. Jensen, C. Andreasen, and M. Andersen The functional pro129Thr variant of the FAAH gene is not associated with various fat accumulation phenotypes in a population-based cohort of 5801 whites J Mol Med 85 2007 445 449
10. J. Aberle, I. Fedderwitz, N. Klages, E. George, and F.U. Beil Genetic variation in two proteins of the endocannabinoid system and their influence on body mass index and metabolism under low fat diet Horm Metab Res 39 2007 395 397
11. M.J. Duart, C.O. Arroyo, and J.L. Moreno Validation of a insulin model for the reactions in RIA Clin Chem Lab Med 40 2002 1161 1167
12. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2487
13. American Diabetes Association Standards of diabetes mellitus Diabetes Care 30 2007 s4 s41
14. K.P. Chiang, A.L. Gerber, J.C. Sipe, and B.F. Cravatt Reduced cellular expression and activity of the P129T mutant fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use Hum Mol Genet 13 2004 2113 2119
15. D. Papazoglou, I. Panagopoulos, and N. Papanas The FAAH Pro129Thr polymorphism is not associated with severe obesity in Greek subjects Horm Metab Res 40 2008 907 910
16. V. Di Marzo, S.K. Goparaju, and L. Wang Leptin Regulated endocannabinoids are involved in maintaining food intake Nature 410 2001 822 825
17. M. Egertova, B.F. Cravatt, and M.R. Elphick Comparative analysis of FAAH and CB1 canabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signalling Neuroscience 119 2003 481 496
18. Izzo AA, Piscitelli F, Capasso R, et al. Basal and fasting/refeeding- regulated tissue levels of endogenous PPAR-alpha ligands in Zucker rats. Obesity Epub 2009 Jun 11.